The carcinogenicity of human papillomavirus types reflects viral evolution - PubMed (original) (raw)
. 2005 Jun 20;337(1):76-84.
doi: 10.1016/j.virol.2005.04.002.
Rolando Herrero, Rob Desalle, Allan Hildesheim, Sholom Wacholder, Ana Cecilia Rodriguez, Maria C Bratti, Mark E Sherman, Jorge Morales, Diego Guillen, Mario Alfaro, Martha Hutchinson, Thomas C Wright, Diane Solomon, Zigui Chen, John Schussler, Philip E Castle, Robert D Burk
Affiliations
- PMID: 15914222
- DOI: 10.1016/j.virol.2005.04.002
Free article
The carcinogenicity of human papillomavirus types reflects viral evolution
Mark Schiffman et al. Virology. 2005.
Free article
Abstract
Persistent infections with carcinogenic human papillomaviruses (HPV) cause virtually all cervical cancers. Cervical HPV types (n > 40) also represent the most common sexually transmitted agents, and most infections clear in 1-2 years. The risks of persistence and neoplastic progression to cancer and its histologic precursor, cervical intraepithelial neoplasia grade 3 (CIN3), differ markedly by HPV type. To study type-specific HPV natural history, we conducted a 10,000-woman, population-based prospective study of HPV infections and CIN3/cancer in Guanacaste, Costa Rica. By studying large numbers of women, we wished to separate viral persistence from neoplastic progression. We observed a strong concordance of newly-revised HPV evolutionary groupings with the separate risks of persistence and progression to CIN3/cancer. HPV16 was uniquely likely both to persist and to cause neoplastic progression when it persisted, making it a remarkably powerful human carcinogen that merits separate clinical consideration. Specifically, 19.9% of HPV16-infected women were diagnosed with CIN3/cancer at enrollment or during the five-year follow-up. Other carcinogenic types, many related to HPV16, were not particularly persistent but could cause neoplastic progression, at lower rates than HPV16, if they did persist. Some low-risk types were persistent but, nevertheless, virtually never caused CIN3. Therefore, carcinogenicity is not strictly a function of persistence. Separately, we noted that the carcinogenic HPV types code for an E5 protein, whereas most low-risk types either lack a definable homologous E5 ORF and/or a translation start codon for E5. These results present several clear clues and research directions in our ongoing efforts to understand HPV carcinogenesis.
Similar articles
- Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Herrero R, et al. J Infect Dis. 2005 Jun 1;191(11):1796-807. doi: 10.1086/428850. Epub 2005 May 2. J Infect Dis. 2005. PMID: 15871111 - Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM. Wheeler CM. Obstet Gynecol Clin North Am. 2008 Dec;35(4):519-36; vii. doi: 10.1016/j.ogc.2008.09.006. Obstet Gynecol Clin North Am. 2008. PMID: 19061814 Review. - Age-related changes of the cervix influence human papillomavirus type distribution.
Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodríguez AC, Bratti MC, Hildesheim A, Wacholder S, Long LR, Neve L, Pfeiffer R, Burk RD. Castle PE, et al. Cancer Res. 2006 Jan 15;66(2):1218-24. doi: 10.1158/0008-5472.CAN-05-3066. Cancer Res. 2006. PMID: 16424061 - Human papillomavirus: often harmless but in some cases carcinogenic.
[No authors listed] [No authors listed] Prescrire Int. 2007 Jun;16(89):115-9. Prescrire Int. 2007. PMID: 17585425 - Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Bosch FX, et al. Vaccine. 2008 Aug 19;26 Suppl 10:K1-16. doi: 10.1016/j.vaccine.2008.05.064. Vaccine. 2008. PMID: 18847553 Review.
Cited by
- First Report of Phodopus sungorus Papillomavirus Type 1 Infection in Roborovski Hamsters (Phodopus roborovskii).
Gimpelj Domjanič G, Hošnjak L, Lunar MM, Skubic L, Zorec TM, Račnik J, Cigler B, Poljak M. Gimpelj Domjanič G, et al. Viruses. 2021 Apr 23;13(5):739. doi: 10.3390/v13050739. Viruses. 2021. PMID: 33922632 Free PMC article. - The Role of Zinc in Antiviral Immunity.
Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. Read SA, et al. Adv Nutr. 2019 Jul 1;10(4):696-710. doi: 10.1093/advances/nmz013. Adv Nutr. 2019. PMID: 31305906 Free PMC article. Review. - HPV in HIV-Infected Women: Implications for Primary Prevention.
McKenzie ND, Kobetz EN, Ganjei-Azar P, Rosa-Cunha I, Potter JE, Morishita A, Lucci JA 3rd, Guettouche T, Hnatyszyn JH, Koru-Sengul T. McKenzie ND, et al. Front Oncol. 2014 Aug 12;4:179. doi: 10.3389/fonc.2014.00179. eCollection 2014. Front Oncol. 2014. PMID: 25161956 Free PMC article. - Genetic and Epigenetic Variations of HPV52 in Cervical Precancer.
Bee KJ, Gradissimo A, Chen Z, Harari A, Schiffman M, Raine-Bennett T, Castle PE, Clarke M, Wentzensen N, Burk RD. Bee KJ, et al. Int J Mol Sci. 2021 Jun 16;22(12):6463. doi: 10.3390/ijms22126463. Int J Mol Sci. 2021. PMID: 34208758 Free PMC article. - Molecular diagnosis and phylogenetic analysis of human papillomavirus type-16 from suspected patients in Pakistan.
Abdullah A, Qasim M, Shafiq M, Ijaz M, Parveen S, Murtaza S, Javed Q, Malik SA, Tarar SH, Mehmood S, Sami A, Naqvi SM, Hyder MZ. Abdullah A, et al. Infect Agent Cancer. 2016 Jan 12;11:1. doi: 10.1186/s13027-016-0047-z. eCollection 2016. Infect Agent Cancer. 2016. PMID: 26766963 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical